Buscar en
International Journal of Clinical and Health Psychology
Toda la web
Inicio International Journal of Clinical and Health Psychology Antenatal depressive symptoms are strongly predicted by the severity of pre-mens...
Journal Information
Vol. 23. Issue 2.
(April - June 2023)
Share
Share
Download PDF
More article options
Visits
1092
Vol. 23. Issue 2.
(April - June 2023)
Original article
Open Access
Antenatal depressive symptoms are strongly predicted by the severity of pre-menstrual syndrome: results of partial least squares analysis
Visits
1092
Yoshiko Abea,b, Wandee Sirichokchatchawana,c,
Corresponding author
wandee.s@chula.ac.th

Corresponding author at: College of Public Health Sciences (CPHS), Chulalongkorn University, Chulalongkorn 62, Phyathai Rd, Pathumwan, Bangkok 10330, Thailand; Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Henri Dunant Road, Pathumwan, Bangkok 10330, Thailand.
, Ussanee Sangkomkamhangd, Sirina Satthapisite, Michael Maesf,g,h,
Corresponding author
dr.michaelmaes@hotmail.com

Corresponding author at: College of Public Health Sciences (CPHS), Chulalongkorn University, Chulalongkorn 62, Phyathai Rd, Pathumwan, Bangkok 10330, Thailand; Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Henri Dunant Road, Pathumwan, Bangkok 10330, Thailand.
a College of Public Health Sciences (CPHS), Chulalongkorn University, Bangkok 10330, Thailand
b Department of Public Health, Dokkyo Medical University School of Medicine, Tochigi 321-0293, Japan
c Health and Social Sciences and Addiction Research Unit, Chulalongkorn University, Bangkok, Thailand
d Department of Obstetrics and Gynecology, Khon Kaen Hospital, Khon Kaen 40000, Thailand
e Department of Psychiatry, Khon Kaen Hospital, Khon Kaen 40000, Thailand
f Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
g Department of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria
h IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Abstract

Background/Objective: Antenatal depression (AD) is the commonest morbidity during pregnancy. There is evidence that premenstrual syndrome (PMS) and AD share common immune-inflammatory and sex hormonal pathways. This study aims to evaluate the association between the severity of depressive PMS and AD in early and late pregnancy. Method: Participants were followed from early (<=16 weeks) to late pregnancy (>=20 weeks). The Premenstrual Symptoms Screening Tool (PSST) was used to assess PMS and AD symptoms were assessed using the Edinburgh Postnatal Depression Scale (EPDS). Results: Up to 57.6% of the variance in the early EPDS score was explained by the regression on the first factor extracted from 10 depression and anxiety PSST items (dubbed the DepAnx PSST), insomnia PSST, relation dissatisfaction, and partner abuse. There were specific indirect effects of DepAnx PSST (p < 0.001), insomnia PSST (p = 0.041), relation dissatisfaction (p = 0.023) and partner abuse (p = 0.007) on the late EPDS which were mediated by the early EPDS score. Conclusion: The affective, but not psychosomatic, symptoms of PMS strongly predict AD symptoms suggesting that the pathophysiology of affective PMS symptoms overlap with those of AD.

Keywords:
Perinatal depression
Premenstrual syndrome
Neuro-immune
Inflammation
Oxidative stress
Full Text
Introduction

Antenatal depression (AD) is the commonest morbidity during pregnancy with an estimated prevalence of around 18% (Bennett et al., 2004; Gavin et al., 2005). Untreated AD is a global public health concern with adverse sequelae for maternal and offspring well-being (Roomruangwong et al., 2017). AD increases the risk of preterm birth, low birth weight, operational delivery, and preeclampsia, and also affects child neurocognitive development and behavior outcomes later in life (Gentile, 2017; Grigoriadis et al., 2013; Grote et al., 2010; Hu et al., 2015; Jarde et al., 2016). Furthermore, perinatal depression is associated with maternal and familiar distress, suicidal risk, and adverse childhood experiences including child abuse (Abe et al., 2022; Ayers et al., 2019; Duan et al., 2019). AD severity is strongly predicted by psychological stressors such as relation dissatisfaction, unintended pregnancy, abuse by the partner and early lifetime trauma (Abe et al., 2022). According to a recent systematic review of large population-based studies, depression is more prevalent during pregnancy than after birth (17% vs. 13%). 39% of those with AD went on to develop postpartum depression (PPD), making AD one of the most significant risk factors for PPD (Underwood et al., 2016).

Many women of reproductive age also experience one or more emotional, behavioral, and physical symptoms in the premenstrual phase of the menstrual cycle, which is known as premenstrual syndrome (PMS) (Kwan & Onwude, 2015; Roomruangwong & Maes, 2021). The point prevalence of PMS is estimated between 20 and 30% (Yonkers & Simoni, 2018). Although most of the symptoms are mild, 1.2–6.4% of reproductive women suffer from moderate to severe symptoms, dubbed premenstrual dysphoric disorder (PMDD), which is defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (Yonkers & Simoni, 2018). The typical mood and behavioral symptoms of PMS/PMDD, namely irritability, tension, depressed mood, tearfulness and mood swings, may lead to substantial social, occupational, and interpersonal impairment (Kwan & Onwude, 2015; Roomruangwong & Maes, 2021). The symptoms often worsen substantially 6 days before the menses and peak around 2 days before the menses whilst there is a symptom-free interval before ovulation (Yonkers et al., 2008).

On the other hand, there is now evidence that PMS or better Menstrual Cycle – Associated Syndrome (MCAS, which offers better diagnostic criteria than PMS and PMDD) (Roomruangwong & Maes, 2021) is characterized by specific alterations in sex hormones indicative of relative corpus luteum insufficiency and alterations in the uterine-brain axis with specific alterations in chemokine levels, bacterial antigens and nitro-oxidative stress biomarkers (Roomruangwong et al., 2019; Roomruangwong et al., 2020a; Roomruangwong et al., 2020b). In addition, other research also indicates that inappropriate inflammatory responses and oxidative stress might contribute to the etiology of PMS (Granda et al., 2021). A recent systematic review concluded that PMS may be accompanied by a decreased antioxidant status and increased inflammatory potential (Granda et al., 2021). Furthermore, menstruation-related symptoms, including low abdominal cramps, gastro-intestinal (GI) and pain symptoms, are strongly associated with inflammatory and antioxidant biomarkers (Roomruangwong et al., 2021).

It is important to note that major depression (Maes & Carvalho, 2018), AD (Sawyer, 2021), and PPD (Roomruangwong et al., 2018) are characterized by activated immune-inflammatory and oxidative stress pathways. Moreover, there are studies that PMDD may predict perintal depression (mostly postpartum), and that this association may be attributed to genetic similarities as well as to sex hormonal pathways (McEvoy et al., 2017; Pope et al., 2017). As such, PMS, AD, and PPD may share common immune-inflammatory and sex hormonal pathways (Engler-Chiurazzi et al., 2022; Lombardo et al., 2021); therefore, clinical associations between both conditions may be anticipated. However, most of the current studies focus on associations between PMS and PPD (Pereira et al., 2022), and only few studies have shown that women with PMS symptoms showed increased risk towards AD (Sugawara, 1997; Pataky & Ehlert, 2020). Therefore, investigating the association between PMS and AD or perinatal depression can provide meaningful information for further understanding of reproductive depressive disorders.

There is also evidence that adverse childhood experiences (ACEs) are strongly associated with the onset of AD (Abe et al., 2022), major depressive disorder (Maes et al., 2019; Maes et al., 2022), and possibly PMS (Jacobs et al., 2015; Yang et al., 2022). Such findings suggest that ACEs may underlie the association between PMS and AD. However, no data have investigated whether ACEs may explain the co-occurrence of the affective or physiosomatic (previously denoted as psychosomatic) symptoms of PMS and depressive symptoms during pregnancy.

Hence, the present study aims to determine the association between PMS severity and its symptomatic subdomains (affective versus physiosomatic) and AD during early and late pregnancy, as well as whether this association can be explained by other psychological stressors, such as ACEs. Based on the shared pathophysiology of PMS and AD, the primary hypothesis is that PMS predicts AD symptoms during early and late pregnancy and that ACEs impact those associations.

MethodParticipants

This study was conducted at the Khon Kaen Hospital Antenatal Care (ANC) Center in Khon Kaen, Thailand. The hospital is classified as a regional hospital. Khon Kaen is one of the most populous provinces in Thailand's Northeast. A trained researcher evaluated the eligibility of all pregnant women attending the ANC based on predetermined inclusion and exclusion criteria. Thai pregnant women between the ages of 18 and 49, residing in the Northeast of Thailand, planning to continue ANC treatment in the hospital until birth, being able to read and write Thai, and possessing a mobile phone met the inclusion criteria. Women diagnosed with any axis-I mental disorder other than depression, including schizophrenia, bipolar disorder, generalized anxiety disorder, substance abuse disorders, and psycho-organic disorders, as well as neuroinflammatory or (auto)immune disorders (such as psoriasis, rheumatoid arthritis, inflammatory bowel disease and systemic lupus erythematosus), and women taking antidepressants or mood stabilizers were excluded from the study. Among the 120 women, who participated in the early prenatal phase (gestational week <=16), 96 were able to be assessed in the late prenatal phase (gestational week >=20). Twenty-four women withdrew after the initial phase, opting for follow-up at alternative hospitals. All women provided written informed consent. The Institutional Review Boards (IRBs) of the Khon Kaen Hospital and Chulalongkorn University (KEF62036 and COA No. 280/2019, respectively) approved the study.

Instruments and procedure

During normal prenatal appointments, early (gestational week =<16) and late (gestational week >=20) pregnancy data were collected. The sociodemographic data included age, pre-pregnancy body mass index (BMI), level of education, number of children, and age of the partner. Medical records were reviewed for obstetric information such as AD/PPD history, gravidity, parity, and cesarean delivery history. Relationship satisfaction was assessed using a 4-point Likert scale from “satisfied” to “dissatisfied”.

The Edinburgh Postnatal Depression Scale (EPDS) was used to evaluate AD symptoms (Cox et al., 1987). EPDS is the most popular and reliable instrument for assessing depression during pregnancy (Bunevicius et al., 2009). It comprises of 10 questions on a four-point Likert scale (scores range from 0 to 3; total score varies from 0 to 30) and measures the mother's mood throughout the previous week. The validated cutoff value for screening pregnant women in the Thai version of the EPDS was 10 (area under the curve: AUC 0.84, sensitivity 60%, and specificity 90%) (Pitanupong et al., 2007). This scale has strong reliability and validity, as indicated by a research conducted in the upper Northeast area of Thailand among pregnant women in their third trimester (Item-Objective-congruence: IOC = 0.90; Cronbach's Alpha = 0.83) (Phoosuwan et al., 2017).

The Thai version of the Premenstrual Symptoms Screening Tool (PSST) was used to assess PMS symptoms. The premenstrual symptoms (#1-14: 14 items) and its consequences in various situations (A-E: 5 items) are measured on a four-point Likert scale ranging from "not at all" to "mild" to "moderate" to "severe" and scored from 1 to 4 (Steiner et al., 2003). Cronbach's alpha was more than 0.9 for all domains when evaluating the validity of the Thai version (Chayachinda et al., 2008).

The Multidimensional Scale of Perceived Social Support (MSPSS) measures perceived social support (Zimet et al., 1988). The MSPSS is comprised of 12 items scored on a seven-point Likert scale. Family support, friend support, and significant other support are subdomains. Wongpakaran et al. (2018) developed a validated Thai version. In addition, this questionnaire was utilized to evaluate pregnant women's social support in Thailand's Northeast area (Phoosuwan et al., 2018).

The Abuse Assessment Screen (AAS) was used to assess intimate relationship abuse (McFarlane, 1992). AAS is one of the most extensively used screening instruments for intimate partner violence in the pregnant population and consists of five yes/no questions (Deshpande & Lewis-O Connor, 2013). "Yes" item to any question implies abuse. Previously, we detected that AAS item 1 is most important item to predict AD (Abe et al., 2022).

The Adverse Childhood Experiences Questionnaire (ACE questionnaire) was used to evaluate adverse childhood experiences (Felitti et al., 1998). It comprises 28 questions organized into 10 items, namely psychological abuse, physical abuse, sexual abuse, mental neglect, physical neglect, domestic violence, substance misuse in the family, family psychiatric disease, separation or divorce in the family, and family members with criminal behaviors. Using all ACE items, we conducted factor analysis and identified two factors, namely a) mental and physical neglect (dubbed ACE neglect) and b) psychological, physical, and sexual abuse, domestic violence, a family history of substance misuse, and a family history of psychiatric disease (dubbed ACE Family-Dysfunction & Abuse or ACE-FDA) (Abe et al., 2022). Therefore, we used the ACE neglect and ACE-FDA factor scores in the present study.

Data analysis

We utilized analysis of variance (ANOVA) to compare continuous variables between study groups and the Chi-squares (χ2) or Fisher's exact probability test to compare categories. Using Pearson's product-moment correlation coefficients, associations between continuous variables were analyzed. We used Generalized Estimating Equation analysis, repeated measures, to examine the differences in EDPS scores between early and late pregnancy. Manual multiple regression analysis was used to identify the most influential variables (entered as input variables based on expert opinion or prior knowledge of causal links) predicting the early and late EPDS scores (entered as output variables). In addition, we performed automatic stepwise (forward selection with p-to-enter of 0.05 and p-to-remove of 0.06) regression analysis to select the most or best predictor set of input variables. The stepwise method was used to investigate various combinations of predictors that could have been missed using the manual method. Because automatic stepwise regression may lead to overfitting and may not always select the best input variables and may not always lead to replicable findings, we believe that it is always most appropriate to combine distinct regression methods. In addition, we always conduct hierarchical multiple regression analysis to determine the effects of some explanatory variables above and beyond the effects of others. As a result, we constructed the most appropriate regression model while taking predictor quality into account. The outcomes of multiple regression analysis were always checked for multicollinearity and heteroscedasticity. Principal component analysis (PCA) was employed as a feature reduction method, not to interpret the factor structure after varimax rotation. Therefore, we extracted only the first PC of strongly correlated variables as assessed using the correlation matrix. The Kaiser-Meyer-Olkin measure of sampling adequacy (KMO) statistic and Bartlett's test were utilized to examine the data's factoriability. To be accepted as an adequate component, the variance explained should be > 50.0% and all items should load highly (>0.6) on the component. When performing PCA we always use the rule of thumb that the sample size should be 10 times larger than the number of variables and that there should be at least 3 variables in a PC. All statistical analyses were conducted using version 25 of IBM SPSS for Windows. A priori estimation of the sample size using G*Power, showed that for a multiple regression analysis with 6 predictors, effect size = 0.2, p = 0.05 and power=0.8, the estimated sample size should be at least 75.

In addition, we utilized Partial Least Squares (PLS) analysis to investigate the causal effects of ACEs on the EPDS scores and whether these effects are mediated by PSST scores. The latter were introduced as a latent vector extracted from the PSST items. The AAS1, unplanned pregnancy and relation satisfaction (and socio-demographic data) were entered as other predictors of the EPDS scores. The latter variables, early and late EPDS, and the ACE subdomains were entered as single indicators. Complete PLS analysis was performed when the model quality data met the following predetermined criteria: (a) the outer model should have adequate construct validity with AVE>0.5, Cronbach alpha > 0.7, rho_A>0.75 and composite reliability >0.8; (b) the standardized root mean square (SRMR) should be < 0.080 (conservative criterion); (c) the original values of the squared Euclidean distance (d ULS) and the geodesic distance (d G) are included in the confidence intervals, (d) blindfolding demonstrates adequate cross validated redundancies; and (e) PLS Confirmatory Tetrad Analysis shows that the constructs are not mis-specified as a reflective model. Consequently, we conducted complete PLS analysis with 5000 bootstrap samples and computed pathway coefficients with exact p-value, indicator loadings in the outer model (with p values), specific indirect effects, total indirect effects, and total effects.

ResultsSocio-demographic and clinical data

Table 1 shows the socio-demographic data of women with and without antenatal depression. There were no significant differences in age, BMI, education, number of children, age of the partner, score of a significant other and family, sexual abuse, mental neglect, and psychiatric family history. There were significant differences in score of friends, total PSS, EPDS total, psychological and physical abuse, physical neglect, domestic violence, substance use disorder (SUD) in family, household dysfunction, and ACE total.

Table 1.

Baseline characteristics of women with and without antenatal depression (AD).

  ADNo AD
  n =34n = 86F/χ2/FFPTdfp-value
Age (years)  27.4  6.0  27.1  5.3  0.08  1/118  0.772 
Pre-pregnancy BMI (kg/m2)  23.2  3.8  23.4  5.8  0.02  1/118  0.898 
Education level  3.3  1.3  3.6  1.3  1.18  1/118  0.280 
Number of children  0.7  0.7  0.7  0.6  0.32  1/118  0.575 
Partner age (years)  31.4  8.6  29.7  6.0  1.44  1/118  0.232 
MSPSS significant other  5.4  1.0  5.6  1.2  0.83  1/118  0.365 
MSPSS family  5.9  1.0  6.2  0.8  3.35  1/118  0.070 
MSPSS friends  4.7  1.3  5.6  1.0  13.48  1/118  <0.001 
MSPSS total  5.4  0.9  5.8  0.8  7.14  1/118  0.009 
Total PSST  32.9  6.4  24.0  4.8  67.70  1/118  <0.001 
EPDS total  12.3  2.8  3.5  2.6  274.13  1/118  <0.001 
Psychological abuse  3.1  1.7  2.3  0.8  13.06  1/118  <0.001 
Physical abuse  2.6  1.4  2.0  0.2  12.07  1/118  <0.001 
Sexual abuse  0.1  0.3  0.1  0.4  0.39  1/118  0.536 
Mental neglect  10.9  5.0  9.2  4.1  3.68  1/118  0.057 
Physical neglect  9.5  3.7  7.7  2.9  7.27  1/118  0.008 
Domestic violence  4.6  2.0  4.1  0.4  4.84  1/118  0.030 
Substance abuse in the family  0.2  0.5  0.0  0.2  5.86  1/118  0.017 
Family psychiatric illness  0.1  0.3  0.0  0.2  0.19  1/118  0.666 
Separation or divorce in the family  0.5  0.5  0.3  0.5  3.68  1/118  0.057 
Family members are criminals  0.1  0.3  0.1  0.2  0.35  1/118  0.555 
Household dysfunction  5.4  2.7  4.5  0.8  7.73  1/118  0.006 
ACE neglect  20.4  8.0  16.9  6.3  6.17  1/118  0.014 
ACE-FDA  10.5  4.8  8.5  1.1  13.83  1/118  <0.001 
ACE total score  31.6  11.1  25.9  6.8  11.81  1/118  <0.001 
AD/PPD history (n, %)  33  97.1  83  96.5  ‒  ‒  1.000 
  2.9  3.5       
Planned pregnancy (n, %)  11  32.4  65  75.6  19.61  <0.001 
  23  67.6  21  24.4       
Gravidity (times) (n, %)  13  38.2  31  36.0  3.02  0.221 
  10  29.4  38  44.2       
  11  32.4  17  19.8       
Parity (times) (n, %)  15  44.1  34  39.5  1.79  0.408 
  14  41.2  45  52.3       
  14.7  8.1       
History of cesarean delivery (n, %)  27  79.4  74  86.0  0.81  0.410 
  20.6  12  14.0       
Relation satisfaction with a partner and family (n, %)27  79.4  83  96.5  ‒  ‒  0.005 
20.6  3.5       
AAS1 (n, %)  23  67.6  79  91.9  11.20  <0.001 
  11  32.4  8.1       

F/χ2/FEPT: all results of analysis of variance (ANOVA), analysis of contingency tables (χ2 Test) or Fisher's Exact Probability test (FEPT).

Results are shown as mean ±standard deviation, or as ratios with percentage.

MSPSS: Multidimensional Scale of Perceived Social Support.

PSST: Premenstrual Symptoms Screening.

EPDS: Edinburgh Postnatal Depression Scale.

ACE: Adverse Childhood Experiences.

ACE neglect: Mental and physical neglect.

ACE-FDA: Family dysfunction and abuse.

AD: Antenatal Depression.

PPD: Post-Partum Depression.

AAS: Abuse Assessment Screen.

AAS1: AAS item 1 Experience of emotional or physical abuse.

Results of factor analysis

We examined whether the total sum of the PSS is an adequate method to reflect severity of PSS and, therefore, examined whether one latent vector with adequate construct validity could be extracted from the items. The first factor extracted from the 14 PSS symptoms explained only 40.9% of the variance (KMO=0.850), while 3 items showed loading <0.6, namely PSS10, PSS11, PSS12 and PSS14. Consequently, we have examined whether one factor with adequate construct validity could be extracted from the ten remaining PSS items. Table 2 shows that one factor could be extracted from PSS items 1, 2, 3, 4, 5, 6, 7, 8, 9 and 13 which explained 50.4% of the variance (KMO=0.878), whilst all loadings were > 0.6. We were also able to extract one factor which explained 50.4% of the variance in PSS10, PSS12 and PSS14, while PSS11 did not load highly on this factor. Therefore, we used the first factor extracted from those 10 PSST (labeled PSST depression-anxiety PC) and 3 PSST (dubbed PSST physiosomatic PC) items as well as PSST item insomnia in subsequent analyses. Table 2 also shows that one adequate factor (dubbed PSST interference PC) could be extracted from all five PSS interference data (A, B, C, D and E) which explained 69.3% of the variance and showed high loadings on the five items (>0.716).

Table 2.

Results of principal component analysis of the Premenstrual Symptoms Screening Tool (PSST) items.

PSST
VariablesPC  VariablesPC  VariablesPC 
PSST 100.641  PSST 10.609  PSST.A0.716 
PSST 120.800  PSST 20.746  PSST.B0.864 
PSST 140.785  PSST 30.722  PSST.C0.816 
  PSST 40.724  PSST.D0.893 
  PSST 50.737  PSST.E0.854 
  PSST 60.750   
  PSST 70.684   
  PSST 80.746   
  PSST 90.729       
  PSST 130.637       
ComponentPC_3PSST  ComponentPC_10PSST  ComponentPC_interference 
KMO0.61  KMO0.88  KMO0.84 
Bartlett's test  Bartlett's test  Bartlett's test 
  χ2  38.85    χ2  554.04    χ2  334.24 
  df    df  45    df  10 
  p-value  <0.001    p-value  <0.001    p-value  <0.001 
Variance explained55.6  Variance explained50.4  Variance explained69.0 

KMO: Kaiser-Meyer-Olkin measure of sampling adequacy.

Differences in PSS scores between women with and without perinatal depression

Table 3 shows the differences in all 14 PSS items between women with and without perinatal depression. All 14 PSS items as well as all 5 PSS interference scores were significantly higher in women with perinatal depression than in those without. The scores of the total summed PSS, PSST depression-anxiety, PSST physiosomatic and PSST interference PC scores were significantly higher in women with perinatal depression than in those without.

Table 3.

Associations between Premenstrual Symptoms Screening (PSS) score and Antenatal Depression (AD).

  ADNo AD
  n=34n=86
PSST scores  Mean  (SDMean  (SDF  df  p-value 
Total PSST  32.9  6.4  24.0  4.8  67.74  1/118  <0.001 
PSST1  2.8  0.6  2.3  0.7  18.06  1/118  <0.001 
PSST2  2.4  0.8  1.7  0.7  26.93  1/118  <0.001 
PSST3  2.5  1.0  1.8  0.8  19.01  1/118  <0.001 
PSST4  2.0  0.8  1.1  0.3  82.97  1/118  <0.001 
PSST5  2.1  0.8  1.4  0.6  26.75  1/118  <0.001 
PSST6  1.9  0.8  1.3  0.6  18.28  1/118  <0.001 
PSST7  2.0  0.7  1.4  0.6  25.39  1/118  <0.001 
PSST8  2.0  0.7  0.0  0.0  31.99  1/118  <0.001 
PSST9  2.8  0.7  2.2  0.7  18.33  1/118  <0.001 
PSST10  2.6  0.8  2.1  0.9  7.62  1/118  0.007 
PSST11  2.0  0.8  1.6  0.7  9.01  1/118  0.003 
PSST12  2.8  1.0  2.3  0.9  9.72  1/118  0.002 
PSST13  1.9  0.8  1.3  0.5  24.43  1/118  <0.001 
PSST14  3.0  0.7  2.4  0.8  14.92  1/118  <0.001 
PSST.A  0.0  0.7  0.0  0.7  9.76  1/118  0.002 
PSST.B  1.8  0.8  1.3  0.6  12.26  1/118  <0.001 
PSST.C  1.8  0.8  1.4  0.7  8.34  1/118  0.005 
PSST.D  1.9  0.8  1.3  0.6  20.52  1/118  <0.001 
PSST.E  2.3  0.9  1.4  0.7  31.40  1/118  <0.001 
PSST depression-anxiety  1.0  1.0  -0.4  0.7  66.95  1/118  <0.001 
PSST physiosomatic  0.6  0.9  -0.2  1.0  20.51  1/118  <0.001 
PSST interference  0.6  1.0  -0.3  0.9  23.55  1/118  <0.001 

F: all results of analysis of variance (ANOVA).

Results are shown as mean with standard deviation (SD).

Associations between PSS, EPDS and ACE scores

Table 4 shows the intercorrelation matrix among PSST scores, EPDS and ACE scores. We found that the EPDS scores in early and late pregnancy were significantly associated with the total PSST score, PSST depression-anxiety PC, PSST interference PC, and PSST insomnia, whilst the early EPDS was additionally associated with the PSST physiosomatic score. The ACE neglect score was positively and significantly associated with the PTSS depression-anxiety PC score. Both EPDS scores were significantly associated with ACE neglect and ACE-FDA scores.

Table 4.

Intercorrelation matrix among Premenstrual Symptoms Screening Tool (PSST), Edinburgh Postnatal Depression Scale (EPDS), and Adverse Childhood Experiences (ACE) scores.

  EPDS late  EPDS early  ACE neglect  ACE-FDA 
  (n = 94)  (n = 120)  (n = 120)  (n = 120) 
EPDS early  0.510 (<0.001)       
ACE neglect  0.360 (<0.001)  0.291 (0.001)     
ACE-FDA  0.306 (0.003)  0.310 (<0.001)  0.350 (<0.001)   
Total PSST  0.421 (<0.001)  0.664 (<0.001)  0.154 (0.092)  0.131 (0.153) 
PSST depression-anxiety PC  0.453 (<0.001)  0.650 (<0.001)  0.249 (0.006)  0.162 (0.077) 
PSST physiosomatic PC  0.124 (0.234)  0.386 (<0.001)  -0.118 (0.199)  0.026 (0.776) 
PSST insomnia  0.261 (0.011)  0.428 (<0.001)  0.009 (0.920)  0.002 (0.984) 
PSST interference PC  0.264 (0.010)  0.469 (<0.001)  0.179 (0.010)  0.156 (0.089) 

ACE neglect: Mental and physical neglect.

ACE-FDA: Family dysfunction and abuse.

Best predictions of the EPDS scores

Table 5 shows the results of multiple regression analysis with EPDS as dependent variables and PSST, ACE neglect, ACE-FDA and AAS1 scores (and socio-demographic data including education, body mass index, parity) as explanatory variables. We found that 31.6% of the variance in the endpoint EPDS score was explained by PSST depression-anxiety PC, ACE total, and AAS1 (all positively associated). After entering the baseline EPDS score in the same regression analysis we found that 32.2% of the variance in the endpoint EPDS score was explained by the regression on baseline EPDS and ACE neglect (both positively associated). The third regression shows that 63.1% of the variance in the early EPDS score was explained by the combined effects of PSST depression-anxiety PC, PSST insomnia, ACE1, AAS1, and relation satisfaction. Fig. 1 shows the partial regression of the early EPDS score on the PSST depression-anxiety PC score.

Table 5.

Results of multiple regression analysis with the early and late Edinburgh Postnatal Depression Scale (EPDS) scores as dependent variables.

Dependent variables  Explanatory variablesModel
    β  t  p-value  F  df  p-value   
Late EPDS          13.84  3/90  <0.001  0.316 
  PSST depression-anxiety PC  0.311  3.26  0.002         
  ACE total score  0.240  2.55  0.012         
  AAS1  0.226  2.49  0.015         
Late EPDS          21.75  2/91  <0.001  0.323 
  Early EPDS  0.466  5.11  <0.001         
  ACEneglect  0.207  2.26  0.026         
Early EPDS          38.96  5/114  <0.001  0.631 
  PSST depression-anxiety PC  0.499  7.53  <0.001         
  ACE1  0.266  4.52  <0.001         
  AAS1  0.147  2.40  0.018         
  PSST insomnia  0.152  2.41  0.018         
  Relation dissatisfaction  0.142  2.31  0.023         

ACE: Adverse Childhood Experiences.

ACE1: ACE item 1 Psychological abuse.

ACEneglect: Mental and physical neglect.

AAS1: AAS item 1 Experience of emotional or physical abuse.

Figure 1.

Partial regression of the early Edinburgh Postnatal Depression Scale (EPDS) score on the Premenstrual Symptoms Screening Tool (PPST) depression-anxiety score.

(0.14MB).

Table 6 shows the results of a GEE repeated measurement analysis with the two EPDS measurements as dependent variables and AAS1 (repeated measures), antenatal depression, time, PSST, ACE scores and items of the ACE as explanatory variables. We found that the changes over time in the EPDS score were best predicted by antenatal depression, time, diagnosis x time interaction, PSST depression-anxiety PC, PSST insomnia, AAS1, ACE1 and ACE neglect. This table also shows the mean EPDS values obtained in early and late pregnancy both in women with and without antenatal depression. The late EPDS score were significantly lower than the baseline EPDS scores while the diagnosis x time interaction pattern may be explained by our findings that in women without antenatal depression there was no effect of time, whereas in those with antenatal depression, the EPDS scores were lower at endpoint than at baseline.

Table 6.

Results of GEE repeated measures analysis with the Edinburgh Postnatal Depression Scale (EPDS) score as dependent variable.

Effects  Early  Late  Wald (df=1)  p-value 
No AD mean (SD4.2 (0.3)  5.0 (0.4)     
AD mean (SD10.4 (0.4)  5.5 (0.6)     
AD38.71  <0.001 
time29.03  <0.001 
time × AD57.93  <0.001 
PSST depression-anxiety PC11.02  <0.001 
PSST insomnia10.45  0.001 
AAS14.51  0.034 
ACE17.74  0.005 
ACE PC15.25  0.022 

AD: Antenatal Depression.

AAS1: AAS item 1 Experience of emotional or physical abuse.

ACE1: ACE item 1 Psychological abuse.

ACE PC1: Mental and physical neglect.

Results of PLS analysis

Fig. 2 shows the results of the final PLS model. The quality of the model was adequate with SRMR=0.054 and the outer model of the latent vector extracted from the 10 PSST depression-anxiety items showed accurate construct validity with composite reliability of 0.910, rho_A of 0.897 and Cronbach alpha of 0.890, and AVE=0.503. The outer loadings were all greater than 0.6 at p < 0.0001. PLS blindfolding showed an adequate construct cross validated redundancy (0.029) and PLS predict showed that this latent vector was not mis-specified as a reflective model. Fig. 2 shows the pathway coefficient with exact p values as well as the variance explained. Thus, we found that 25.1% of the variance in late EPDS was explained by early EPDS and ACE neglect scores. Up to 57.6% of the variance in early EPDS was explained by the regression on PSST depression-anxiety PC, PSST insomnia, relation dissatisfaction and AAS1. Finally, 6.3% of the variance in the first latent vector extracted from the PSST depression-anxiety PC was explained by the mental-physical subdomain of the ACE. There were specific indirect effects of the PSST depression-anxiety latent vector (t=4.16, p < 0.001), PSST insomnia (t=1.74, p = 0.041), relation dissatisfaction (t=1.99, p = 0.023) and AAS1 (t=2.47, p = 0.007) on the late EDPS score which were all mediated via the early EPDS score. There was a significant indirect effect of the ACE neglect score on late EPDS which was mediated by the path from PSST depression-anxiety PC to early EPDS (t=1.99, p = 0.024).

Figure 2.

Results of Partial least Squares (PLS) analysis with the early and late Edinburgh Postnatal Depression Scale (EPDS) scores as output variables and the Premenstrual Symptoms Screening Tool (PPST) depression-anxiety and insomnia scores, relation dissatisfaction, and the Abuse Assessment Screen, item 1 (AAS1) score as direct input variables. Mental-physical (mental-phys) neglect predicted the PSST and EPDS scores. The PSST depression-anxiety score was entered as a latent vector extracted from 10 PSST items, whilst all other variables were entered as single indicators. This final PLS model shows only the significant paths. In this model, the PSST depression-anxiety partly mediates the effect of mental-physical neglect on the early and thus late EPDS scores. Shown are path coefficients (with exact p values) and loadings (with p values) on the PSST latent vector. The white figures in the blue circles indicate explained variance.

(0.5MB).
DiscussionAffective and physiosomatic subdomains of the PSST

The first major finding of this study is that the PSST rating scale, when used in pregnant females, does not have sufficient convergence and construct validity. For the sum of all items of a rating scale score to be regarded accurate, the test's factorial structure must be unidimensional, namely it should contain one general factor explaining more than 50 percent of the variance and all items included should have significant and high loadings (>0.6) on this factor (Hemrungrojn et al., 2022). Without a general factor, the overall sum score will not reflect the overarching construct (Sala et al., 2020). In the present study we found that the first factor extracted from the 14 PSST symptoms explained only 40.9% of the variance while some items showed insufficient loadings of <0.6. We found that the PSST comprises 2 meaningful factors, namely a first with PSST items 1, 2, 3, 4, 5, 6, 7, 8, 9 and 13 (dubbed the PSST depression-anxiety factor) and a second with 3 physiosomatic items (PSS10, PSS12 and PSS14, dubbed the PSST physiosomatic factor) and one solitary item, namely PSST insomnia. One factor with adequate construct validity could be extracted from the five PSST interference data (A, B, C, D and E, dubbed PSST inference PC) and, consequently, we used these two PSST construct scores, insomnia and PSST inference PC in our analysis. In another exploratory factor analysis study, four domains were retrieved namely decreased interest in daily activities, interference with normal function, instability of mood and psychophysical distress (Pacitti et al., 2021).

Association between PSST scores and prenatal depression

The second major finding of the present study is that all PTSS item and subdomain scores were significantly higher in women with AD than in those without and that the severity of the PSST depression-anxiety factor score, PSST insomnia as well as relation dissatisfaction and the experience of partner abuse significantly predicted depressive EPDS symptoms during pregnancy. In fact, those explanatory variables explained 63.0% of the variance in early pregnancy EPDS scores, whilst the PSST depression-anxiety PC was the single best predictor of severity of AD symptoms. Moreover, the association between the PSST depression-anxiety factor score and depressive symptoms in late pregnancy was mediated by the depressive symptoms in early pregnancy. As such the affective, but not physiosomatic, symptoms of PMS largely predict the depressive symptoms during early and late pregnancy, whereas insomnia has a significant effect be it with a smaller effect size.

Limited studies showed positive associations between PMS and affective disorders during pregnancy. One study identified that women with mood changes (irritability) during the premenstrual period had significantly higher depression scores than those without throughout pregnancy (early, middle, and late pregnancy) and the postpartum period as well (5 days, 1 month, and 6 months after childbirth) (Sugawara et al., 1997). Another study revealed that having symptoms of PMS prior to the current pregnancy was associated with increased odds of antenatal depression (OR: 2.828 [95% CI 1.337–5.983]) (Pataky & Ehlert, 2020). Our findings extend these previous studies showing that PMS is strongly associated with depressive symptoms during pregnancy and, additionally, emphasized the effect of affective symptoms and insomnia, but not physiosomatic, symptoms, during the premenstrual period on depressive symptoms during pregnancy.

Effects of ACEs

The third main finding of the current study is that mental and physical neglect had a substantial impact on the early pregnancy EPDS score, as well as the late EPDS score. As a result, our findings extend those of a recent meta-analysis reporting that ACEs significantly increase the risk of mother depression and/or anxiety throughout the perinatal period (Racine et al., 2021). Other studies also support that ACEs such as physical, emotional and sexual abuse, physical and emotional neglect, and home dysfunctions) were linked to mental distress during pregnancy (Li et al., 2017; Racine et al., 2018; Shamblaw et al., 2019).

Another significant finding of the current study is that the link between mental and physical neglect and depressed symptoms in early and late pregnancy was partially mediated by the PSST depression-anxiety PC score. Furthermore, the path from PSST depression-anxiety symptoms to early pregnancy EPDS partially mediated the effects of mental and physical neglect on late pregnancy EDPS scores. This is an example of partial mediation whereby the affective symptoms of PMS partially mediate the effects of ACEs on depressive symptoms during pregnancy. This is also an example of distal mediation because the effect of the affective symptoms of PMS on the EDPS score was much more important than the effect of mental and physical neglect on PMS.

A population-based study that looked at the relationship between cumulative and individual ACE exposure and premenstrual disorders, such as PMS and PMDD, discovered a positive, linear relationship between the cumulative number of ACEs and likely premenstrual disorders (PR: 1.12, 95 percent CI: 1.11–1.13). The latter were linked to sexual abuse, emotional neglect, familial violence, a household member's mental illness, as well as peer and communal violence (Yang et al., 2022). Another study found that women who were abused as children had a significantly higher incidence of premenstrual syndrome (OR: 1.47, 95 percent CI: 1.20–1.88). Physical or emotional maltreatment as a youngster was found to be strongly linked to PMS (Ito et al., 2021). ACEs are risk factors for antenatal mental health disorders, according to a previous mediation analysis, and these effects are mediated by past depressions and unfavorable adult experiences (Lydsdottir et al., 2019). In women with low levels of current resilience, ACE exposure strongly predicts poor mental and behavioral health during pregnancy (Young-Wolff et al., 2019).

Adverse outcome pathways linking mental and physical neglect, PMS and AD symptoms

The interrelationships among the PSST affective symptoms of PMS and perinatal depressive symptoms and the effects of ACEs may be explained by the effects of adverse outcome pathways. Thus, there is evidence that a) PMS (or better MCAS) and menstrual distress are in part due to immune-inflammatory processes (Roomruangwong & Maes, 2021); b) major depression and perinatal depression are associated with activated immune-inflammatory pathways; and c) ACEs induce an immune-inflammatory and growth factor response which is a major determinant of the phenome of depression (Maes et al., 2022). Moreover, psychosocial stressors including relation dissatisfaction and abuse by the partner during pregnancy may further exacerbate those immune-inflammatory pathways. It is indeed well-known that even mild psychological stressors induce and immune-inflammatory response as well as T cell activation (Maes et al., 1998; Maes et al., 1999). It is interesting to note that these stress effects on the cytokine network are pronounced in subjects with lowered levels of omega-3 polyunsaturated fatty acids (Maes et al., 2000) which is known to predict depressive symptoms in the perinatal period (De Vriese et al., 2003). Consequently, the main hypothesis is that ACE-induced immune responsivity contributes to PMS and perinatal depression, and that the sex-hormone alterations leading to PMS (Roomruangwong & Maes, 2021) aggravate the immune response thereby aggravating perinatal depression.

Limitations

There are a few limitations to this research. First, the EPDS score was collected by self-report. Second, the PSST and ACEs questionnaires are completed retrospectively by the participants and, hence, they may have been prone to recollection bias. Second, the sample size is rather small, and this could have influenced the statistical power and the precision of the parameter estimates. Nevertheless, a priori estimation showed that for a power of 0.8, the estimated sample size should be at least 75. Moreover, post-hoc G*Power analysis given the results of our PLS analysis and an explained variance of 57.6% (in early EPDS scores) the actual power is 1.0. Lastly, our data were obtained at a regional hospital, which is typical of the Northeast area of Thailand and, therefore, our findings may not be generalizable.

Conclusions

The present study demonstrated that the affective symptoms and sleep disturbance of PMS strongly predict depressive symptoms during early pregnancy, and that this the latter mediates the effects of PMS affective symptoms on late pregnancy depressive symptoms. Moreover, mental and physical neglect have a significant effect on the depressive symptoms during pregnancy which are only partly mediated by the affective symptoms of PMS. Excessive activation of immune-inflammatory pathways may underpin the premenstrual, early and late pregnancy affective symptoms and these pathways are partly activated by ACEs. Further research should focus on the contribution of immune-inflammatory and associated nitro-oxidative pathways on the affective symptoms of PMS (better MCAS), pregnancy and the postnatal period.

Funding

This research project is supported by Ratchadapiseksompotch Fund Chulalongkorn University.

Acknowledgments

We are grateful to all the participants for their time and efforts for this study. We also acknowledge with appreciation the staff of ANC at Khon Kaen hospital who greatly helped with the data collection.

References
[Abe et al., 2022]
Y. Abe, W. Sirichokchatchawan, U. Sangkomkamhang, S. Satthapisit, M. Maes.
Adverse childhood experiences combined with emotional and physical abuse by the partner predict antenatal depression.
Journal of Affective Disorders, 298 (2022), pp. 194-201
[Ayers et al., 2019]
S. Ayers, R. Bond, R. Webb, P. Miller, K. Bateson.
Perinatal mental health and risk of child maltreatment: A systematic review and meta-analysis.
Child Abuse & Neglect, 98 (2019),
[Bennett et al., 2004]
H.A. Bennett, A. Einarson, A. Taddio, G. Koren, T.R. Einarson.
Prevalence of depression during pregnancy: Systematic review.
Obstetrics & Gynecology, 103 (2004), pp. 698-709
[Bunevicius et al., 2009]
A. Bunevicius, L. Kusminskas, V.J. Pop, C.A. Pedersen, R. Bunevicius.
Screening for antenatal depression with the Edinburgh depression scale.
Journal of Psychosomatic Obstetrics & Gynecology, 30 (2009), pp. 238-243
[Chayachinda, Rattanachaiyanont, Phattharayuttawat and Kooptiwoot, 2008]
C. Chayachinda, M. Rattanachaiyanont, S. Phattharayuttawat, S. Kooptiwoot.
Premenstrual syndrome in Thai nurses.
Journal of Psychosomatic Obstetrics & Gynecology, 29 (2008), pp. 199-205
[Cox, Holden and Sagovsky, 1987]
J.L. Cox, J.M. Holden, R. Sagovsky.
Detection of postnatal depression. Development of the 10-item Edinburgh postnatal depression scale.
British Journal of Psychiatry, 150 (1987), pp. 782-786
[Deshpande and Lewis-O'Connor, 2013]
N.A. Deshpande, A Lewis-O'Connor.
Screening for intimate partner violence during pregnancy.
Reviews in Obstetrics & Gynecology, 6 (2013), pp. 141-148
[De Vriese, Christophe and Maes, 2003]
S.R. De Vriese, A.B. Christophe, M. Maes.
Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: Further evidence that lowered n-PUFAs are related to major depression.
Life Sciences, 73 (2003), pp. 3181-3187
[Duan et al., 2019]
Z. Duan, Y. Wang, Y. Tao, J.L. Bower, R. Yu, S. Wang, Z. Wu, Y. Lv, X. Yang, X. Li, L. Huang, L. Ma, Q. Dong, J. Sun, S. Li, Y. Yang, Y. Yang, K. Peng, R. Chen.
Relationship between trait neuroticism and suicidal ideation among postpartum women in China: Testing a mediation model.
Journal of Affective Disorders, 256 (2019), pp. 532-535
[Engler-Chiurazzi et al., 2022]
E.B. Engler-Chiurazzi, W.H. Chastain, K.K. Citron, L.E. Lambert, D.N. Kikkeri, S.S. Shrestha.
Estrogen, the Peripheral immune system and major depression - a reproductive lifespan perspective.
Frontiers in Behavioral Neuroscience, 16 (2022),
[Felitti et al., 1998]
V.J. Felitti, R.F. Anda, D. Nordenberg, D.F. Williamson, A.M. Spitz, V. Edwards, M.P. Koss, J.S. Marks.
Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The adverse childhood experiences (ACE) study.
American Journal of Preventive Medicine, 14 (1998), pp. 245-258
[Gavin et al., 2005]
N.I. Gavin, B.N. Gaynes, K.N. Lohr, S. Meltzer-Brody, G. Gartlehner, T. Swinson.
Perinatal depression - A systematic review of prevalence and incidence.
Obstetrics & Gynecology, 106 (2005), pp. 1071-1083
[Gentile, 2017]
S. Gentile.
Untreated depression during pregnancy: Short- and long-term effects in offspring. A systematic review.
Neuroscience, 342 (2017), pp. 154-166
[Granda, Szmidt and Kaluza, 2021]
D. Granda, M.K. Szmidt, J. Kaluza.
Is premenstrual syndrome associated with inflammation, oxidative stress and antioxidant status? A systematic review of case-control and cross-sectional studies.
Antioxidants, 10 (2021), pp. 604
[Grigoriadis et al., 2013]
S. Grigoriadis, E.H. VonderPorten, L. Mamisashvili, G. Tomlinson, C.L. Dennis, G. Koren, M. Steiner, P. Mousmanis, A. Cheung, K. Radford, J. Martinovic, L.E. Ross.
The impact of maternal depression during pregnancy on perinatal outcomes: A systematic review and meta-analysis.
Journal of Clinical Psychiatry, 74 (2013), pp. e321-e341
[Grote et al., 2010]
N.K. Grote, J.A. Bridge, A.R. Gavin, J.L. Melville, S. Iyengar, W.J. Katon.
A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction.
Archives of General Psychiatry, 67 (2010), pp. 1012-1024
[Hemrungrojn, Amrapala and Maes, 2022]
S. Hemrungrojn, A. Amrapala, M. Maes.
Construction of a short version of the Montreal cognitive assessment (MoCA) rating scale using partial least squares analysis.
International Journal of Neuroscience, 12 (2022), pp. 1-12
[Hu, Li, Zhang and Yan, 2015]
R. Hu, Y. Li, Z. Zhang, W. Yan.
Antenatal depressive symptoms and the risk of preeclampsia or operative deliveries: A meta-analysis.
[Ito, Doi, Isumi and Fujiwara, 2021]
K. Ito, S. Doi, A. Isumi, T. Fujiwara.
Association between childhood maltreatment history and premenstrual syndrome.
International Journal of Environmental Research and Public Health, 18 (2021), pp. 781
[Jacobs, Boynton-Jarrett and Harville, 2015]
M.B. Jacobs, R.D. Boynton-Jarrett, E.W. Harville.
Adverse childhood event experiences, fertility difficulties and menstrual cycle characteristics.
Journal of Psychosomatic Obstetrics & Gynecology, 36 (2015), pp. 46-57
[Jarde et al., 2016]
A. Jarde, M. Morais, D. Kingston, R. Giallo, G.M. MacQueen, L. Giglia, J. Beyene, Y. Wang, S.D. McDonald.
Neonatal outcomes in women with untreated antenatal depression compared with women without depression: A systematic review and meta-analysis.
Journal of the American Medical Association Psychiatry, 73 (2016), pp. 826-837
[Kwan and Onwude, 2015]
I. Kwan, J.L. Onwude.
Premenstrual syndrome.
British Medical Journal Clinical Evidence, 2015 (2015), pp. 0806
[Li, Long, Cao and Cao, 2017]
Y. Li, Z. Long, D. Cao, F. Cao.
Maternal history of child maltreatment and maternal depression risk in the perinatal period: A longitudinal study.
Child Abuse & Neglect, 63 (2017), pp. 192-201
[Lombardo, Mondelli, Dazzan and Pariante, 2021]
G. Lombardo, V. Mondelli, P. Dazzan, C.M. Pariante.
Sex hormones and immune system: A possible interplay in affective disorders? A systematic review.
Journal of Affective Disorders, 290 (2021), pp. 1-14
[Lydsdottir et al., 2019]
L.B. Lydsdottir, L.M. Howard, H. Olafsdottir, H. Einarsson, T. Steingrimsdottir, J.F. Sigurdsson.
Adverse life experiences and common mental health problems in pregnancy: A causal pathway analysis.
Archives of Women's Mental Health, 22 (2019), pp. 75-83
[Maes and Carvalho, 2018]
M. Maes, A.F. Carvalho.
The compensatory immune-regulatory reflex system (CIRS) in depression and bipolar disorder.
Molecular Neurobiology, 55 (2018), pp. 8885-8903
[Maes et al., 2000]
M. Maes, A. Christophe, E. Bosmans, A. Lin, H. Neels.
In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to psychologic stress.
Biological Psychiatry, 47 (2000), pp. 910-920
[Maes et al., 2019]
M. Maes, J.B. Moraes, A. Congio, K.L. Bonifacio, D.S. Barbosa, H.O. Vargas, A.P. Michelin, A.F. Carvalho, S.O.V. Nunes.
Development of a novel staging model for affective disorders using partial least squares bootstrapping: Effects of lipid-associated antioxidant defenses and neuro-oxidative stress.
Molecular Neurobiology, 56 (2019), pp. 6626-6644
[Maes et al., 2022]
M. Maes, M. Rachayon, K. Jirakran, P. Sodsai, S. Klinchanhom, M. Debnath, A. Basta-Kaim, M. Kubera, A.F. Almulla, A. Sughondhabirom.
Adverse childhood experiences predict the phenome of affective disorders and these effects are mediated by staging, neuroimmunotoxic and growth factor profiles.
[Maes et al., 1998]
M. Maes, C. Song, A. Lin, R. De Jongh, A. Van Gastel, G. Kenis, E. Bosmans, I. De Meester, I. Benoy, H. Neels, P. Demedts, A. Janca, S. Scharpe, R.S. Smith.
The effects of psychological stress on humans: Increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety.
Cytokine, 10 (1998), pp. 313-318
[Maes et al., 1999]
M. Maes, D.R. Van Bockstaele, A. Gastel, C. Song, C. Schotte, H. Neels, I. DeMeester, S. Scharpe, A. Janca.
The effects of psychological stress on leukocyte subset distribution in humans: Evidence of immune activation.
Neuropsychobiology, 39 (1999), pp. 1-9
[McEvoy, Osborne, Nanavati and Payne, 2017]
K. McEvoy, L.M. Osborne, J. Nanavati, J.L. Payne.
Reproductive affective disorders: A review of the genetic evidence for premenstrual dysphoric disorder and postpartum depression.
Current Psychiatry Reports, 19 (2017), pp. 94
[McFarlane, Parker, Soeken and Bullock, 1992]
J. McFarlane, B. Parker, K. Soeken, L. Bullock.
Assessing for abuse during pregnancy: Severity and frequency of injuries and associated entry into prenatal care.
Journal of the American Medical Association, 267 (1992), pp. 3176-3178
[Pacitti et al., 2021]
F. Pacitti, C. Iorio, G. Riccobono, A. Iannitelli, A. Pompili.
Assessment of premenstrual symptoms: Validation of the Italian version of the premenstrual symptoms screening tool.
Rivista di Psichiatria, 56 (2021), pp. 246-253
[Pataky and Ehlert, 2020]
E.A. Pataky, U. Ehlert.
Longitudinal assessment of symptoms of postpartum mood disorder in women with and without a history of depression.
Archives of Women's Mental Health, 23 (2020), pp. 391-399
[Pereira et al., 2022]
D. Pereira, A.R. Pessoa, N. Madeira, A. Macedo, A.T. Pereira.
Association between premenstrual dysphoric disorder and perinatal depression: A systematic review.
Archives of Women's Mental Health, 25 (2022), pp. 61-70
[Phoosuwan, Eriksson and Lundberg, 2017]
N. Phoosuwan, L. Eriksson, P.C. Lundberg.
Statistical analysis of the Thail version of the Edinburgh Postnatal Depression Scale among women during the antenatal period in North-east Thaialnd.
Proceedings of the 5th PSU-USM International conference on arts and sciences,
[Phoosuwan, Eriksson and Lundberg, 2018]
N. Phoosuwan, L. Eriksson, P.C. Lundberg.
Antenatal depressive symptoms during late pregnancy among women in a north-eastern province of Thailand: Prevalence and associated factors.
Asian Journal of Psychiatry, 36 (2018), pp. 102-107
[Pitanupong, Liabsuetrakul and Vittayanont, 2007]
J. Pitanupong, T. Liabsuetrakul, A. Vittayanont.
Validation of the Thai Edinburgh postnatal depression scale for screening postpartum depression.
Psychiatry Research, 149 (2007), pp. 253-259
[Pope, Oinonen, Mazmanian and Stone, 2017]
C.J. Pope, K. Oinonen, D. Mazmanian, S. Stone.
The hormonal sensitivity hypothesis: A review and new findings.
Medical hypotheses, 102 (2017), pp. 69-77
[Racine et al., 2021]
N. Racine, C. Devereaux, J.E. Cooke, R. Eirich, J. Zhu, S. Madigan.
Adverse childhood experiences and maternal anxiety and depression: A meta-analysis.
BMC Psychiatry, 21 (2021), pp. 28
[Racine et al., 2018]
N. Racine, S. Madigan, A. Plamondon, E. Hetherington, S. McDonald, S. Tough.
Maternal adverse childhood experiences and antepartum risks: The moderating role of social support.
Archives of Women's Mental Health, 21 (2018), pp. 663-670
[Roomruangwong et al., 2018]
C. Roomruangwong, G. Anderson, M. Berk, D. Stoyanov, A.F. Carvalho, M. Maes.
A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression.
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 81 (2018), pp. 262-274
[Roomruangwong et al., 2017]
C. Roomruangwong, D.S. Barbosa, A.K. Matsumoto, A.D. Nogueira, B. Kanchanatawan, S. Sirivichayakul, A.F. Carvalho, S. Duleu, M. Geffard, E.G. Moreira, M. Maes.
Activated neuro-oxidative and neuro-nitrosative pathways at the end of term are associated with inflammation and physio-somatic and depression symptoms, while predicting outcome characteristics in mother and baby.
Journal of Affective Disorders, 223 (2017), pp. 49-58
[Roomruangwong, Carvalho, Geffard and Maes, 2019]
C. Roomruangwong, A.F. Carvalho, M. Geffard, M. Maes.
The menstrual cycle may not be limited to the endometrium but also may impact gut permeability.
Acta Neuropsychiatrica, 31 (2019), pp. 294-304
[Roomruangwong and Maes, 2021]
C. Roomruangwong, M. Maes.
Biomarker validation of a new case definition of menstrual cycle-associated syndrome (MCAS) opinion paper.
CNS & Neurological Disorders Drug Targets, 20 (2021), pp. 105-111
[Roomruangwong et al., 2020a]
C. Roomruangwong, A.K. Matsumoto, A.P. Michelin, L. de Oliveira Semeao, J.V. de Lima Pedrao, E.G. Moreira, S. Sirivichayakul, A. Carvalho, D.S. Barbosa, M. Maes.
The role of immune and oxidative pathways in menstrual cycle associated depressive, physio-somatic, breast and anxiety symptoms: Modulation by sex hormones.
Journal of Psychosomatic Research, 135 (2020),
[Roomruangwong, Sirivichayakul, Carvalho and Maes, 2020b]
C. Roomruangwong, S. Sirivichayakul, A.F. Carvalho, M. Maes.
The uterine-chemokine-brain axis: Menstrual cycle-associated symptoms (MCAS) are in part mediated by CCL2, CCL5, CCL11, CXCL8 and CXCL10.
Journal of Affective Disorders, 269 (2020), pp. 85-93
[Roomruangwong et al., 2021]
C. Roomruangwong, S. Sirivichayakul, A.K. Matsumoto, A.P. Michelin, L. de Oliveira Semeao, J.V. de Lima Pedrao, D.S. Barbosa, E.G. Moreira, M. Maes.
Menstruation distress is strongly associated with hormone-immune-metabolic biomarkers.
Journal of Psychosomatic Research, 142 (2021),
[Sala et al., 2020]
G. Sala, H. Inagaki, Y. Ishioka, Y. Masui, T. Nakagawa, T. Ishizaki, Y. Arai, K. Ikebe, K. Kamide, Y. Gondo.
The psychometric properties of the montreal cognitive assessment (MoCA).
Swiss Journal of Psychology, 79 (2020), pp. 155-161
[Sawyer, 2021]
K.M. Sawyer.
The role of inflammation in the pathogenesis of perinatal depression and offspring outcomes.
Brain Behavior and Immunity Health, 18 (2021),
[Shamblaw, Cardy, Prost and Harkness, 2019]
A.L. Shamblaw, R.E. Cardy, E. Prost, K.L. Harkness.
Abuse as a risk factor for prenatal depressive symptoms: A meta-analysis.
Archives of Women's Mental Health, 22 (2019), pp. 199-213
[Steiner, Macdougall and Brown, 2003]
M. Steiner, M. Macdougall, E. Brown.
The premenstrual symptoms screening tool (PSST) for clinicians.
Archives of Women's Mental Health, 6 (2003), pp. 203-209
[Sugawara et al., 1997]
M. Sugawara, M.A. Toda, S. Shima, T. Mukai, K. Sakakura, T. Kitamura.
Premenstrual mood changes and maternal mental health in pregnancy and the postpartum.
Journal of Clinical Psychology, 53 (1997), pp. 225-232
[Underwood et al., 2016]
L. Underwood, K. Waldie, S. D'Souza, E.R. Peterson, S Morton.
A review of longitudinal studies on antenatal and postnatal depression.
Archives of Women's Mental Health, 19 (2016), pp. 711-720
[Wongpakaran et al., 2018]
T. Wongpakaran, N. Wongpakaran, T. Sirirak, S. Arunpongpaisal, G. Zimet.
Confirmatory factor analysis of the revised version of the Thai multidimensional scale of perceived social support among the elderly with depression.
Aging & Mental Health, 22 (2018), pp. 1143-1148
[Yang et al., 2022]
Q. Yang, E.B. Thornorethardottir, A. Hauksdottir, T. Aspelund, J. Jakobsdottir, T. Halldorsdottir, G. Tomasson, H. Runarsdottir, H.B. Danielsdottir, E.R. Bertone-Johnson, A. Sjolander, F. Fang, D. Lu, U.A. Valdimarsdottir.
Association between adverse childhood experiences and premenstrual disorders: A cross-sectional analysis of 11,973 women.
BMC Medicine, 20 (2022), pp. 60
[Yonkers, O'Brien and Eriksson, 2008]
K.A. Yonkers, P.M.S. O'Brien, E. Eriksson.
Premenstrual syndrome.
The Lancet, 371 (2008), pp. 1200-1210
[Yonkers and Simoni, 2018]
K.A. Yonkers, M.K. Simoni.
Premenstrual disorders.
American Journal of Obstetrics & Gynecology, 218 (2018), pp. 68-74
[Young-Wolff et al., 2019]
K.C. Young-Wolff, A. Alabaster, B. McCaw, N. Stoller, C. Watson, S. Sterling, K.K. Ridout, T. Flanagan.
Adverse childhood experiences and mental and behavioral health conditions during pregnancy: The role of resilience.
Journal of Women's Health, 28 (2019), pp. 452-461
[Zimet, Dahlem, Zimet and Farley, 1988]
G.D. Zimet, N.W. Dahlem, S.G. Zimet, G.K. Farley.
The multidimensional scale of perceived social support.
Journal of Personality Assessment, 52 (1988), pp. 30-41
Copyright © 2022. The Authors
Article options
Tools